本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Entrada Therapeutics, Inc.

12.59
-0.1500-1.18%
盤後12.590.00000.00%16:10 EDT
成交量:11.30萬
成交額:143.49萬
市值:4.81億
市盈率:-3.62
高:13.07
開:12.75
低:12.41
收:12.74
52周最高:13.66
52周最低:4.93
股本:3,821.92萬
流通股本:2,158.20萬
量比:0.59
換手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-3.4746
每股收益(LYR):-3.4746
淨資產收益率:-39.13%
總資產收益率:-21.58%
市淨率:1.57
市盈率(LYR):-3.62

資料載入中...

2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/08

重要事件披露

Form 8-K - Current report
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities